Organisation paid for research Program year 2025 Source: CMS Open Payments

Kur Research LLC

Neither a doctor nor a teaching hospital

Research payments

$752,167

63 payments

Through program year 2025, Kur Research LLC is reported as receiving $752,167 in research payments, across 63 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$391,563	34
2024	Research	$50,272	15
2023	Research	$282,427	13
2022	Research	$27,905	1

Breakdown

Who paid Research payments · program years 2022–2025

Ortho-Clinical Diagnostics, Inc. $319,686 14 payments
Becton, Dickinson and Company $196,253 7 payments
Gen-Probe, Inc. $54,885 11 payments
Genzyme Corporation $47,772 14 payments
Cue Health Inc. $37,349 1 payment
Pfizer Inc. $31,132 5 payments
Amgen Inc. $28,403 2 payments
Moderna TX, Inc. $23,988 8 payments
Sekisui Diagnostics LLC $12,700 1 payment

Studies the money was for Research payments · program years 2022–2025

Triplex $172,748 2 payments
Respiratory Virus Sample Collection $163,341 10 payments
Savanna RVP4X Assay $156,345 4 payments
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma $47,772 14 payments
Cp-Ctng $37,349 1 payment
655-A10940-001 $33,185 10 payments
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age $23,988 8 payments
A Phase 2B Doubleblind Randomized Placebocontrolled Parallel Group Dose Ranging Study to Evaluate Virological Response and Safety of Oral Pf07817883 in Nonhospitalized Symptomatic Adult Participants With Covid19 $23,200 3 payments
Covid-19 $22,165 2 payments
A10940-SC2/FluP-CSP-02 $21,700 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.